Latest filing published 13 Jun 2025 for Mirum Pharmaceuticals, Inc., €135k.
Filing timeline
BuySaleInsider track record
William Fairey: trading record in brief
William Fairey has filed trades across 2 companies (mainly through SEC (Form 4)), most often in MyoKardia, Inc. and Mirum Pharmaceuticals, Inc. Between 1 February 2020 and 11 June 2025, the trades on record add up to 5 filings.
The open-market record consists of 2 sales worth €314k, with no purchase. Outside the open market, there are 2 option exercises. 2025 to date brings no purchases and 1 sale.
On 13 June 2025 came the latest disclosure, an open-market sale for €135k in Mirum Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to William Fairey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,203 shares@ US$48.4204100.0% of flowCommon StockSEC:0001415889-25-017188:0
- 5,703 sharesCommon StockSEC:0001415889-25-015302:0
- 42,199 sharesCommon StockSEC:0000899243-20-031757:0
- 2,899 shares@ US$68.04100.0% of flowCommon StockSEC:0000899243-20-002644:1
- 8,125 sharesCommon StockSEC:0000899243-20-002644:0
5 of 5 declarations
